<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04859881</url>
  </required_header>
  <id_info>
    <org_study_id>HGAM01</org_study_id>
    <nct_id>NCT04859881</nct_id>
  </id_info>
  <brief_title>Risk Factors for Barotrauma in COVID-19</brief_title>
  <official_title>Risk Factors Associated With Barotrauma in COVID-19 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Ajusco Medio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Horacio Marquez-Gonzalez</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Carlos Torruco-Sotelo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sebastian Rodriguez-Llamazares</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital General Ajusco Medio</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Barotrauma in mechanical ventilation (MV) is defined as lung damage attributable to the&#xD;
      application of high airway pressure and is one of the potential mechanisms of&#xD;
      ventilator-induced lung injury (VILI). Previous studies have shown an increased mortality in&#xD;
      patients with barotrauma under MV; pneumothorax (PTX) being the most common presentation, but&#xD;
      it can also present as pneumomediastinum (PM) with or without PTX, with extension to soft&#xD;
      tissue as subcutaneous emphysema or even as pneumo-retroperitoneum and pneumo-scrotum.&#xD;
&#xD;
      Traditionally, underlying lung disease or age are known risk factors for non-trauma related&#xD;
      barotrauma. However, in patients with novel coronavirus disease (COVID-19), the incidence of&#xD;
      this complication is more common than in non-infected patients, as recently reported. Since&#xD;
      little is known regarding which are the main risk factors for these events to develop, most&#xD;
      pathophysiological mechanisms remain unexplained.&#xD;
&#xD;
      The aim of this study was to determine the risk factors for developing barotrauma in patients&#xD;
      under MV with COVID-19 associated Acute Respiratory Distress Syndrome (ARDS). Secondary&#xD;
      objectives were to determine the incidence of barotrauma and its association with mortality.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Actual">January 31, 2021</completion_date>
  <primary_completion_date type="Actual">January 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Barotrauma development</measure>
    <time_frame>During patient hospitalization, an average of one month</time_frame>
    <description>Diagnosis of barotrauma in patients under mechanical ventilation with COVID-19 associated Acute Respiratory Distress Syndrome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>During patient hospitalization, an average of one month</time_frame>
    <description>Dead of patient</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">262</enrollment>
  <condition>Barotrauma</condition>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Barotrauma/cases</arm_group_label>
    <description>Cases were defined as patients with barotrauma consulted with the Surgery Department</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No braotruma/Controls</arm_group_label>
    <description>Controls were selected from a random sample of the COVID-19-ARDS cohort.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Barotrauma/cases</arm_group_label>
    <arm_group_label>No braotruma/Controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diagnosis of severe SARS-COV2 infection and mechanical ventilation, admitted&#xD;
        in a single-center community Hospital in Mexico City.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients under MV fulfilling the Berlin definition for ARDS, with positive SARS-COV2&#xD;
             real time polymerase chain reaction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Incomplete clinical records and other causes of extrapulmonary air&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital General Ajusco Medio</name>
      <address>
        <city>Mexico city</city>
        <zip>14250</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 19, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2021</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Ajusco Medio</investigator_affiliation>
    <investigator_full_name>Karla Ver√≥nica Chavez-Tostado</investigator_full_name>
    <investigator_title>Head of Surgery Department</investigator_title>
  </responsible_party>
  <keyword>Barotrauma</keyword>
  <keyword>COVID-19</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Barotrauma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

